| NPM-ALK is a key regulator of the oncoprotein FOXM1 in ALK-positive anaplastic large cell lymphoma M Haque, J Li, YH Huang, M Almowaled, CJ Barger, AR Karpf, P Wang, ... Cancers 11 (8), 1119, 2019 | 7 | 2019 |
| Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment V Stavrou, L Fultang, S Booth, D De Simone, A Bartnik, U Scarpa, L Gneo, ... Cancer Immunology, Immunotherapy 72 (3), 543-560, 2023 | 5 | 2023 |
| Three-dimensional reconstructed bone marrow matrix culture improves the viability of primary myeloma cells in-vitro via a STAT3-dependent mechanism YH Huang, M Almowaled, J Li, C Venner, I Sandhu, A Peters, ... Current Issues in Molecular Biology 43 (1), 313-323, 2021 | 4 | 2021 |
| MLL-AF9-Induced Leukaemia Changes during Ontogenic Stages MS Almowaled, L Liu, K Dunn, MMK Aung, G Horne, J Schwaller, ... Blood 142, 2761, 2023 | | 2023 |
| NPM-ALK is a key regulator of the oncoprotein FOXM1 in ALK-positive anaplastic large cell lymphoma: identification of a novel role for NPM1 in the pathobiology of NPM-ALK M Haque, J Li, YH Huang, M Almowaled, CJ Barger, AR Karpf, P Wang, ... | | |
